Federal Register #2026-22611

CMS requests comments on three information collections submitted for OMB review

CMS is seeking public comments on three information collections submitted for OMB review; this notice is not a procurement or award. - Government buyer: Centers for Medicare & Medicaid Services (CMS), within the U.S. Department of Health and Human Services (HHS). - Information collections under review: - CMS-10302: Requirements for compendia used to determine medically accepted indications for off-label uses of drugs and biologicals in cancer chemotherapy regimens; 845 respondents and 900 annual responses. - CMS-10346: Appeals of Medicare Advantage Quality Bonus Payment determinations; 20 respondents and 20 annual responses. - CMS-10105: In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey mode experiment; 211,770 respondents and annual responses. - Comments sought: Feedback on the collections’ need and utility, estimated burden, clarity and quality of information, and ways to reduce burden, including through technology. - Procurement details: No vendors, OEMs, products, or services are being solicited.

Description

CMS is requesting public comments on three proposed information collections under the Paperwork Reduction Act. The collections concern compendia requirements for off-label cancer drug indications, appeals of Quality Bonus Payment determinations, and an In-Center Hemodialysis CAHPS survey mode experiment. Comments must be received by the OMB desk officer by December 7, 2026.

View original listing